• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非 COVID-19 相关实验室分析物变化与 SARS-CoV-2 以及 HIV、TB 和 HbA1c 的关系。

COVID-19-Related Laboratory Analyte Changes and the Relationship Between SARS-CoV-2 and HIV, TB, and HbA1c in South Africa.

机构信息

Department of Chemical Pathology, University of the Witwatersrand; National Health Laboratory Service, Johannesburg, South Africa.

Department of Chemical Pathology, University of Cape Town; National Health Laboratory Service, Cape Town, South Africa.

出版信息

Adv Exp Med Biol. 2021;1321:183-197. doi: 10.1007/978-3-030-59261-5_16.

DOI:10.1007/978-3-030-59261-5_16
PMID:33656724
Abstract

We conducted a retrospective analysis on data of all adults tested for SARS-CoV-2 across our laboratory network in South Africa over a 4-month period. Out of 842,197 tests, 11.7% were positive and 88.3% negative. The prevalence of HIV was 6.25 and 6.31% in the SARS-CoV-2-positive and SARS-CoV-2-negative cohort, respectively (p = 0.444). However, the prevalence of HIV-positive individuals in the critical cohort (9.15%) was higher than in the noncritical group (6.24%) (p = 0.011). Active tuberculosis infection was approximately 50% less in SARS-CoV-2-positive than in SARS-CoV-2-negative individuals. The prevalence of uncontrolled diabetes was 3.4 times higher in SARS-CoV-2-positive cases but was not higher in the critical vs. noncritical cases (p = 0.612). The neutrophil-to-lymphocyte ratio, coagulation markers, urea, and cardiac- and liver-related analytes were significantly elevated in the critical compared to noncritical cases. Platelet count and creatinine concentration did not differ significantly between the two groups. These findings do not support increased prevalence of HIV or tuberculosis in individuals with SARS-CoV-2 infection but do suggest an association of increased disease severity with HIV-positive status. Uncontrolled diabetes was positively associated with a significantly higher prevalence of SARS-CoV-2, and our investigation into analyte changes associated with SARS-CoV-2 disease severity supported previous findings of raised inflammatory markers, coagulation markers, liver- and cardiac-related analytes, and urea but not for creatinine and platelet count.

摘要

我们对南非实验室网络在 4 个月期间检测的所有成年人的 SARS-CoV-2 数据进行了回顾性分析。在 842197 次检测中,有 11.7%呈阳性,88.3%呈阴性。SARS-CoV-2 阳性和 SARS-CoV-2 阴性队列中的 HIV 患病率分别为 6.25%和 6.31%(p=0.444)。然而,危重组中 HIV 阳性个体的患病率(9.15%)高于非危重组(6.24%)(p=0.011)。SARS-CoV-2 阳性个体的活动性肺结核感染率比 SARS-CoV-2 阴性个体低约 50%。SARS-CoV-2 阳性病例中未控制的糖尿病患病率高 3.4 倍,但在危重与非危重病例中并无更高(p=0.612)。中性粒细胞与淋巴细胞比值、凝血标志物、尿素以及心脏和肝脏相关分析物在危重病例中明显高于非危重病例。血小板计数和肌酐浓度在两组之间无显著差异。这些发现不支持 SARS-CoV-2 感染个体中 HIV 或结核病的患病率增加,但确实表明与 HIV 阳性状态相关的疾病严重程度增加。未控制的糖尿病与 SARS-CoV-2 感染的患病率显著增加呈正相关,我们对与 SARS-CoV-2 疾病严重程度相关的分析物变化的调查支持先前关于炎症标志物、凝血标志物、肝脏和心脏相关分析物以及尿素升高的发现,但肌酐和血小板计数除外。

相似文献

1
COVID-19-Related Laboratory Analyte Changes and the Relationship Between SARS-CoV-2 and HIV, TB, and HbA1c in South Africa.南非 COVID-19 相关实验室分析物变化与 SARS-CoV-2 以及 HIV、TB 和 HbA1c 的关系。
Adv Exp Med Biol. 2021;1321:183-197. doi: 10.1007/978-3-030-59261-5_16.
2
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.南非高 HIV 和结核病流行地区 COVID-19 相关住院死亡率的危险因素:一项队列研究。
Lancet HIV. 2021 Sep;8(9):e554-e567. doi: 10.1016/S2352-3018(21)00151-X. Epub 2021 Aug 4.
3
High HIV prevalence in an early cohort of hospital admissions with COVID-19 in Cape Town, South Africa.南非开普敦首批新冠肺炎住院患者队列中艾滋病毒感染率高。
S Afr Med J. 2020 Aug 21;110(10):982-987. doi: 10.7196/SAMJ.2020.v110i10.15067.
4
The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa.南非开普敦高艾滋病毒/结核病负担地区医院环境中 SARS-CoV-2 与非传染性疾病(NCDs)之间的界面。
PLoS One. 2023 Oct 5;18(10):e0277995. doi: 10.1371/journal.pone.0277995. eCollection 2023.
5
The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital.在一家地区医院因 COVID-19 住院的一系列 HIV 感染者的临床和流行病学特征。
BMC Infect Dis. 2023 Feb 28;23(1):123. doi: 10.1186/s12879-023-08004-6.
6
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa.COVID-19:对南非艾滋病毒和结核病应对、服务提供和研究的影响。
Curr HIV/AIDS Rep. 2022 Feb;19(1):46-53. doi: 10.1007/s11904-021-00588-5. Epub 2022 Jan 22.
7
Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa.Cascade 免疫保护机制对抗结核分枝杆菌(IMPAc-TB):南非西开普省家庭接触研究的研究方案。
BMC Infect Dis. 2022 Apr 15;22(1):381. doi: 10.1186/s12879-022-07349-8.
8
Undiagnosed comorbidities among individuals hospitalised with COVID-19 in South African public hospitals.南非公立医院中因新冠肺炎住院患者的未确诊合并症。
S Afr Med J. 2022 Aug 30;112(9):747-752. doi: 10.7196/SAMJ.2022.v112i9.16417.
9
Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory.为下一次大流行做准备:南非一家高通量自动化艾滋病毒分子实验室快速扩大新冠病毒检测规模的经验教训
Int J Infect Dis. 2021 Sep;110:1-3. doi: 10.1016/j.ijid.2021.06.019. Epub 2021 Jun 15.
10
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa.非洲结核病和/或 HIV-1 感染对 COVID-19 表现和免疫反应的影响。
Nat Commun. 2023 Jan 12;14(1):188. doi: 10.1038/s41467-022-35689-1.

引用本文的文献

1
Key Factors Influencing Liver Function Injury in Elderly Patients with Newly Diagnosed Pulmonary Tuberculosis Complicated by Diabetes after Antituberculosis Treatment.抗结核治疗后新诊断为肺结核合并糖尿病老年患者肝功能损伤的相关影响因素
Am J Trop Med Hyg. 2024 Nov 5;112(1):135-142. doi: 10.4269/ajtmh.24-0248. Print 2025 Jan 8.
2
Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort.南非队列中危重症 COVID-19 患者的死亡免疫和血管生物标志物。
Front Immunol. 2023 Jul 3;14:1219097. doi: 10.3389/fimmu.2023.1219097. eCollection 2023.
3
Risk Stratification of COVID-19 Using Routine Laboratory Tests: A Machine Learning Approach.

本文引用的文献

1
Unrecognized diabetes in critically ill COVID-19 patients.危重症COVID-19患者中未被识别的糖尿病
Crit Care. 2020 Jul 9;24(1):406. doi: 10.1186/s13054-020-03139-3.
2
The role of biomarkers in diagnosis of COVID-19 - A systematic review.生物标志物在 COVID-19 诊断中的作用 - 系统评价。
Life Sci. 2020 Aug 1;254:117788. doi: 10.1016/j.lfs.2020.117788. Epub 2020 May 13.
3
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染:49 例首批队列。
使用常规实验室检测对2019冠状病毒病进行风险分层:一种机器学习方法
Infect Dis Rep. 2022 Nov 21;14(6):900-931. doi: 10.3390/idr14060090.
4
Haematological predictors of poor outcome among COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.南非一家三级医院重症监护病房的 COVID-19 患者预后不良的血液学预测因子。
PLoS One. 2022 Nov 4;17(11):e0275832. doi: 10.1371/journal.pone.0275832. eCollection 2022.
5
Prognostic value of biochemical parameters among severe COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.南非一家三级医院重症监护病房收治的重症 COVID-19 患者生化指标的预后价值。
IJID Reg. 2022 Mar;2:191-197. doi: 10.1016/j.ijregi.2022.01.012. Epub 2022 Jan 23.
6
Hematological findings in adult patients with SARS CoV-2 infection at Tygerberg Hospital Cape Town South Africa.南非开普敦泰格堡医院成人新冠病毒2型感染患者的血液学检查结果
Health Sci Rep. 2022 Apr 13;5(3):e550. doi: 10.1002/hsr2.550. eCollection 2022 May.
7
and SARS-CoV-2 Coinfections: A Review.以及新型冠状病毒2型合并感染:一篇综述。
Front Microbiol. 2022 Feb 3;12:747827. doi: 10.3389/fmicb.2021.747827. eCollection 2021.
8
Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis.活动性肺结核与 2019 冠状病毒病:系统评价和荟萃分析。
PLoS One. 2021 Oct 21;16(10):e0259006. doi: 10.1371/journal.pone.0259006. eCollection 2021.
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
4
Covid-19 and acute kidney injury in hospital: summary of NICE guidelines.医院中的新冠病毒病与急性肾损伤:英国国家卫生与临床优化研究所指南摘要
BMJ. 2020 May 26;369:m1963. doi: 10.1136/bmj.m1963.
5
COVID-19 and Multiorgan Response.新型冠状病毒肺炎与多器官反应
Curr Probl Cardiol. 2020 Aug;45(8):100618. doi: 10.1016/j.cpcardiol.2020.100618. Epub 2020 Apr 28.
6
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
7
SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.严重急性呼吸综合征冠状病毒2型与冠状病毒病2019:白细胞介素-6(IL-6)是急性呼吸窘迫综合征发病的“罪魁祸首”吗?除了托珠单抗还有什么?可溶性糖蛋白130融合蛋白(SGP130Fc)
Cytokine X. 2020 Jun;2(2):100029. doi: 10.1016/j.cytox.2020.100029. Epub 2020 May 14.
8
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.糖化血红蛋白与 COVID-19 患者的全身炎症、高凝状态和预后有关。
Diabetes Res Clin Pract. 2020 Jun;164:108214. doi: 10.1016/j.diabres.2020.108214. Epub 2020 May 18.
9
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.感染 COVID-19 的糖尿病患者有更高的 ICU 入住风险和较差的短期预后。
J Clin Virol. 2020 Jun;127:104354. doi: 10.1016/j.jcv.2020.104354. Epub 2020 Apr 9.
10
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.